Attenuation of experimental hepatopulmonary syndrome in endothelin B receptor-deficient rats

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 296, Issue 4, 2009, Pages

  Zhang, Junlan ^a,d   Ling, Yiqun ^a   Tang, Liping ^a,b   Luo, Bao ^a,b   Pollock, David M ^c   Fallon, Michael B ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

^d UNIVERSITY OF TEXAS   (United States)

Author keywords

Common bile duct ligation; Endothelial nitric oxide synthase; Endothelin 1; Intravascular monocyte

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; ENDOTHELIN B RECEPTOR; NITRIC OXIDE; PROTEIN KINASE B; HEME OXYGENASE 1; ONCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE DUCT LIGATION; COMMON BILE DUCT; CONTROLLED STUDY; ENZYME ACTIVATION; GAS EXCHANGE; HEMODYNAMICS; HEPATOPULMONARY SYNDROME; HUMAN; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WILD TYPE; ANIMAL; CHOLESTASIS; GENE DELETION; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; LIVER; METABOLISM; TRANSGENIC ANIMAL; VASCULARIZATION; WISTAR RAT;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CHOLESTASIS; ENDOTHELIN-1; GENE DELETION; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HEME OXYGENASE-1; HEPATOPULMONARY SYNDROME; LIVER; MALE; NITRIC OXIDE SYNTHASE TYPE III; ONCOGENE PROTEIN V-AKT; RATS; RATS, WISTAR; RECEPTOR, ENDOTHELIN B;

EID: 67149118985     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.90627.2008     Document Type: Article

References (29)

1. Fallon MB, Abrams GA, McGrath JW, Hou Z, Luo B. Common bile duct ligation in the rat: a model of intrapulmonary vasodilatation and hepatopulmonary syndrome. Am J Physiol Gastrointest Liver Physiol 272:G779-G784, 1997.
2. Fleming I, Busse R. Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am J Physiol Regul Integr Comp Physiol 284: R1-R12, 2003.
3. Galie N, Manes A, Branzi A. The endothelin system in pulmonary arterial hypertension. Cardiovasc Res 61: 227-237, 2004.
4. Gariepy C, Williams S, Richardson J, Hammer R, Yanagisawa M. Transgenic expression of the endothelin-B receptor prevents congenital intestinal aganglionosis in a rat model of Hirschsprung disease. J Clin Invest 102: 1092-1101, 1998.
5. Gariepy CE, Cases DT, Yanagisawa M. Null mutation of endothelin receptor type B gene in spotting lethal rats causes aganglionic megacolon and white coat color. Proc Natl Acad Sci USA 93: 867-872, 1996.
6. Gariepy CE, Ohuchi T, Williams SC, Richardson JA, Yanagisawa M. Salt-sensitive hypertension in endothelin-B receptor-deficient rats. J Clin Invest 105: 925-933, 2000.
7. Iglarz M, Schiffrin E. Role of endothelin-1 in hypertension. Curr Hypertens Rep 5: 144-148, 2003.
8. Ivy DD, McMurtry IF, Yanagisawa M, Gariepy CE, Cras L, Gebb TD, Morris SA, Wiseman KG, Abman IC, Steven H. Endothelin B receptor deficiency potentiates ET-1 and hypoxic pulmonary vasoconstriction. Am J Physiol Lung Cell Mol Physiol 280: L1040-L1048, 2001.
9. Ivy DD, Yanagisawa M, Gariepy CE, Gebb SA, Colvin KL, McMurtry IF. Exaggerated hypoxic pulmonary hypertension in endothelin B receptor-deficient rats. Am J Physiol Lung Cell Mol Physiol 282:L703-L712, 2002.
10. Kapur RP, Sweetser DA, Doggett B, Siebert JR, Palmiter RD. Intercellular signals downstream of endothelin receptor-B mediate colonization of the large intestine by enteric neuroblasts. Development 121: 3787-3795, 1995.
11. Kawanishi H, Hasegawa Y, Nakano D, Ohkita M, Takaoka M, Ohno Y, Matsumura Y. Involvement of the endothelin ET(B) receptor in gender differences in deoxycorticosterone acetate-salt-induced hypertension. Clin Exp Pharmacol Physiol 34: 280-285, 2007.
12. Kuc RE, Maguire J, Davenport AP. Quantification of endothelin receptor subtypes in peripheral tissues reveals downregulation of ETA receptors in ETB-deficient mice. Exp Biol Med (Maywood) 231: 741-745, 2006.
13. La Villa G, Barletta G, Pantaleo P, Del Bene R, Vizzutti F, Vecchiarino S, Masini E, Perfetto F, Tarquini R, Gentilini P, Laffi G. Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis. Hepatology 34: 19-27, 2001.
14. Ling Y, Zhang J, Luo B, Song D, Liu L, Tang L, Stockard CR, Grizzle WE, Ku DD, Fallon MB. The role of endothelin-1 and the endothelin B receptor in the pathogenesis of hepatopulmonary syndrome in the rat. Hepatology 39: 1593-1602, 2004.
15. Luo B, Abrams GA, Fallon MB. Endothelin-1 in the rat bile duct ligation model of hepatopulmonary syndrome: correlation with pulmonary dysfunction. J Hepatol 29: 571-578, 1998.
16. Luo B, Liu L, Tang L, Zhang J, Stockard CR, Grizzle WE, Fallon MB. Increased pulmonary vascular endothelin B receptor expression and responsiveness to endothelin-1 in cirrhotic and portal hypertensive rats: a potential mechanism in experimental hepatopulmonary syndrome. J Hepatol 38: 556-563, 2003.
17. Matsumura Y, Kuro T, Kobayashi Y, Konishi F, Takaoka M, Wessale JL, Opgenorth TJ, Gariepy CE, Yanagisawa M. Exaggerated vascular and renal pathology in endothelin-B receptor-deficient rats with deoxycorticosterone acetate-salt hypertension. Circulation 102: 2765-2773, 2000.
18. Niederberger M, Martin P, Ginès P, Morris K, Tsai P, Xu DL, McMurtry I, Schrier RW. Normalization of nitric oxide production corrects arterial vasodilation and hyperdynamic circulation in cirrhotic rats. Gastroenterology 109: 1624-1630, 1995.
19. Ohuchi T, Kuwaki T, Ling G, Dewit D, Ju K, Onodera M, Cao W, Yanagisawa M, Kumada M. Elevation of blood pressure by genetic and pharmacological disruption of the ETB receptor in mice. Am J Physiol Regul Integr Comp Physiol 276: R1071-R1077, 1999.
20. Palma DT, Fallon MB. The hepatopulmonary syndrome. J Hepatol 45: 617-625, 2006.
21. Pateron D, Tazi KA, Sogni P, Heller J, Chagneau C, Poirel O, Philippe M, Moreau R, Lebrec D. Role of aortic nitric oxide synthase 3 (eNOS) in the systemic vasodilation of portal hypertension. Gastroenterology 119: 196-200, 2000.
22. Perry MG, Molero M, Giulumian AD, Katakam PVG, Pollock JS, Pollock DM, Fuchs LC. ETB receptor-deficient rats exhibit reduced contraction to ET-1 despite an increase in ETA receptors. Am J Physiol Heart Circ Physiol 281: H2680-H2686, 2001.
23. Pinzani M, Milani S, De Franco R, Grappone C, Caligiuri A, Gentilini A, Tosti-Guerra C, Maggi M, Failli P, Ruocco C, Gentilini P. Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells. Gastroenterology 110: 534-548, 1996.
24. Rodríguez-Roisin R, Krowka MJ, Hervé P, Fallon MB, ERS Task Force Pulmonary-Hepatic Vascular Disorders (PHD) Scientific Committee. Pulmonary-hepatic vascular disorders (PHD). Eur Respir J 24: 861-880, 2004.
25. Schiffrin EL. Endothelin: a role in experimental hypertension. J Cardiovasc Pharmacol 35: S33-S35, 2000.
26. Schiffrin EL. Role of endothelin-1 in hypertension and vascular disease. Am J Hypertens 14: 83s-89s, 2001.
27. Uemasu J, Matsumoto H, Kawasaki H. Increased plasma endothelin levels in patients with liver cirrhosis. Nephron 60: 380, 1992.
28. Zhang J, Ling Y, Luo B, Tang L, Ryter SW, Stockard CR, Grizzle WE, Fallon MB. Analysis of pulmonary heme oxygenase-1 and nitric oxide synthase alterations in experimental hepatopulmonary syndrome. Gastroenterology 125: 1441-1451, 2003.
29. Zhang J, Ling Y, Tang L, Luo B, Chacko BK, Patel RP, Fallon MB. Pentoxifylline attenuation of experimental hepatopulmonary syndrome. J Appl Physiol 102: 949-955, 2007.